L F Iversen - JoVE Visualize

Showing results (1-10 of 13) with videos related to

Pageof 2

Sort By:

Current Opinion in Drug Discovery & Development|August 4, 2009

Protein tyrosine phosphatases (PTPs) as drug targets: inhibitors of PTP-1B for the treatment of diabetesN P Møller, L F Iversen, H S Andersen, et al.

Acta Crystallographica. Section D, Biological Crystallography|October 8, 1998

Atomic resolution structure of human HBP/CAP37/azurocidinS Karlsen, L F Iversen, I K Larsen, et al.

Acta Crystallographica. Section D, Biological Crystallography|November 1, 1996

Crystallization and molecular replacement solution of human heparin binding proteinL F Iversen, J S Kastrup, I K Larsen, et al.

Protein Science : a Publication of the Protein Society|November 5, 1999

Structure and function of the N-linked glycans of HBP/CAP37/azurocidin: crystal structure determination and biological characterization of nonglycosylated HBPL F Iversen, J S Kastrup, S E Bjørn, et al.

Nature Structural Biology|April 1, 1997

Structure of HBP, a multifunctional protein with a serine proteinase foldL F Iversen, J S Kastrup, S E Bjørn, et al.

The Journal of Biological Chemistry|March 4, 2000

2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatasesH S Andersen, L F Iversen, C B Jeppesen, et al.

Nature Medicine|October 9, 2001

Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeabilityN Gautam, A M Olofsson, H Herwald, et al.

The Journal of Biological Chemistry|April 5, 2000

Residue 259 is a key determinant of substrate specificity of protein-tyrosine phosphatases 1B and alphaG H Peters, L F Iversen, S Branner, et al.

Proteins|February 15, 2001

Two mutants of human heparin binding protein (CAP37): toward the understanding of the nature of lipid A/LPS and BPTI bindingJ S Kastrup, V Linde, A K Pedersen, et al.

Protein Science : a Publication of the Protein Society|May 1, 1997

Characterization of the allosteric binding pocket of human liver fructose-1,6-bisphosphatase by protein crystallography and inhibitor activity studiesL F Iversen, M Brzozowski, S Hastrup, et al.

Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:

Pageof 2

Current Opinion in Drug Discovery & Development|August 4, 2009

Protein tyrosine phosphatases (PTPs) as drug targets: inhibitors of PTP-1B for the treatment of diabetesN P Møller, L F Iversen, H S Andersen, et al.

Acta Crystallographica. Section D, Biological Crystallography|October 8, 1998

Atomic resolution structure of human HBP/CAP37/azurocidinS Karlsen, L F Iversen, I K Larsen, et al.

Acta Crystallographica. Section D, Biological Crystallography|November 1, 1996

Crystallization and molecular replacement solution of human heparin binding proteinL F Iversen, J S Kastrup, I K Larsen, et al.

Protein Science : a Publication of the Protein Society|November 5, 1999

Structure and function of the N-linked glycans of HBP/CAP37/azurocidin: crystal structure determination and biological characterization of nonglycosylated HBPL F Iversen, J S Kastrup, S E Bjørn, et al.

Nature Structural Biology|April 1, 1997

Structure of HBP, a multifunctional protein with a serine proteinase foldL F Iversen, J S Kastrup, S E Bjørn, et al.

The Journal of Biological Chemistry|March 4, 2000

2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatasesH S Andersen, L F Iversen, C B Jeppesen, et al.

Nature Medicine|October 9, 2001

Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeabilityN Gautam, A M Olofsson, H Herwald, et al.

The Journal of Biological Chemistry|April 5, 2000

Residue 259 is a key determinant of substrate specificity of protein-tyrosine phosphatases 1B and alphaG H Peters, L F Iversen, S Branner, et al.

Proteins|February 15, 2001

Two mutants of human heparin binding protein (CAP37): toward the understanding of the nature of lipid A/LPS and BPTI bindingJ S Kastrup, V Linde, A K Pedersen, et al.

Protein Science : a Publication of the Protein Society|May 1, 1997

Characterization of the allosteric binding pocket of human liver fructose-1,6-bisphosphatase by protein crystallography and inhibitor activity studiesL F Iversen, M Brzozowski, S Hastrup, et al.

Pageof 2